Chapter 13: Metrics That Matter

Don't be misled by mistaking a flurry of digital activity for actual commercial momentum. Just because your recent LinkedIn post got lots of likes doesn't mean you're moving the needle. We are going to help you delete the dashboard that only tracks vanity metrics and teach you how to measure the numbers that actually signal growth and make investors do a double-take.

In this chapter, we cover:

• The Metrics That Matter Most (and the De-Risking Duo): We break down how to track genuine growth across the four stages of the customer journey—Awareness, Consideration, Conversion, and Loyalty. Plus, we highlight the two mandatory "Commercial De-Risking" metrics (IP Strength and Regulatory Foresight) that prove you have a defensible commercial moat and execution capability.
• Marketing-Qualified vs. Sales-Qualified Leads: Stop treating every website visitor like a guaranteed sale. We explain how to systematically differentiate the "tire kickers" (MQLs) who are just browsing your white papers from the "gold-plated" leads (SQLs) who are ready for a sales pipeline conversation and demo.
• How to Set and Hit KPIs When You Don't Have Historical Data: Navigating the pre-revenue "fog of war" requires a different approach. We teach you how to set hypothesis-driven targets and track "leading indicators" so you can measure momentum and validate your product-market fit before the big revenue numbers arrive.
• Tools That Help (And Ones That Overcomplicate Everything): Don't let your tech stack become a distraction stack. We explore how to build a lean and mean digital toolkit—focusing on essential CRMs, basic web analytics, and email platforms—while ruthlessly cutting complex software that wastes your time and adds noise.
• Reporting Tips That Impress Investors and Keep You Focused: Transform your board updates from boring data dumps into compelling strategic narratives. We outline how to lead with the "So What?", connect your metrics directly to your commercialization goals, and use visual clarity to maintain unwavering investor confidence.

Transcript

Kris 0:00

Chapter thirteen Metrics That Matter Gizmo, please tell me you aren't currently celebrating the fact that our latest LinkedIn post got more likes than a puppy wearing a tiny toot.

Gizmo 0:13

Negative boss. My analysis indicates that likes have an exchange rate of zero when paying for lab space. Vanity metrics are illogical.

Tangela 0:26

From the offices of All Good Life Science Marketing, deep inside the Mars Innovation Hub, this is the Ontario Life Science Founders Marketing Glow Up. A 14-chapter commercialization playbook. Serialized as a podcast. Don't just listen, do the work. Kickstart your glow up with the Free Marketing Foundation's workbook. Five essential step-by-step exercises to craft your venture's commercial platform. Grab your copy now at allgoodmarketing.ca. Now here's Ontario's favorite new marketing duo. All good marketing president and educator Chris Barnett and his high fidelity hype dog, Gizmo.

Kris 1:14

Welcome back to the Ontario Life Sciences Founder Marketing Glow Up.

Gizmo 1:18

The 14-chapter audio playbook, serialized as a podcast where we transform invisible innovators into commercial beasts.

Kris 1:27

We are broadcasting from the all-good life science marketing studio at the Mars Innovation Hub. We are here to help you break the commercialization chokehold by stopping you from mistaking a flurry of activity for actual momentum. Today we are deleting the dashboard that looks pretty but tells you nothing.

Gizmo 1:49

Warning data dump detected. Just because you can measure it does not mean it matters.

Kris 1:55

Exactly, Gizmo. If you can't measure it, you can't scale it. But if you measure the wrong things, you're just scaling noise. We're going to teach you to track the signals that actually make investors do a double take.

Gizmo 2:09

Initiating True North Protocol. Let's glow.

 Metrics that matter: Stop tracking vanity, start tracking value

Kris 2:17

Chapter 13. Stop tracking vanity, start tracking value. Seriously, too many brilliant minds in our sector are mistaking a flurry of activity for actual, honest to goodness, momentum. Just because your LinkedIn post got more likes than a puppy wearing a tiny toque doesn't mean you're actually moving the needle where it counts. This chapter isn't here to track vanity metrics that just hog dashboard space like all those parking violation slips. We're breaking down the marketing and commercial metrics that actually signal the kind of growth that makes investors do a double take. You'll learn how to set key performance indicators, KPIs, that track everything from initial awareness and consideration to full-blown conversion and loyalty. We're diving deeper than your average analytics, showing you what to measure across your content, campaigns, and crucial customer behavior. Additionally, we'll teach you how to align those metrics with your specific business stage goals so your board reports tell a strategic story rather than just a data dump. Whether you're pre-clinical, knee deep in validation, or about to light the fuse on your next funding round, this chapter will sharpen your marketing math. Let's make those numbers sing, eh?

 The 10 metrics that matter most in Ontario life sciences

Kris 3:49

The 10 metrics that matter most in Ontario Life Sciences. Alright, let's get this out of the way. The source material for this chapter flags the 10 metrics that matter most in Ontario Life Sciences as a key topic. However, it doesn't actually hand you a neatly packaged list of the 10. So instead of making something up like a Nathan for You marketing campaign, we're going to focus on the spirit of what matters, moving beyond the likes and views that just look pretty on a dashboard, and digging into the metrics that actually signal real, quantifiable growth. Too many founders confuse being busy with making an impact. Sending out a thousand demos, but not tracking actual conversions. The fundamental metrics track your audience's progress through their journey with you, from their initial interaction to full-fledged fandom. We're talking about indicators that show genuine awareness, deep consideration, successful conversion, and lasting loyalty. It's about measuring impact, not just activity, and distinguishing between broad brand awareness and actual sales pipeline generation. Traction plan. All right, forget trying to track every single thing. We're zeroing in on the signals that actually show you're not just moving, but gaining serious momentum. Focusing on a few key performance indicators, KPIs, can lead to significant improvements. Focus on results and KPIs to help businesses grow. It's about tracking your return on marketing investment, Romy, not just vanity metrics. Here's what you should be eyeing: awareness rock stars. These indicate whether anyone is even aware of your existence. Think unique website visitors, actual eyeballs on your digital space, not just bots, and mentions across media and social platforms. Is anyone talking about your breakthrough beyond your lab? Additionally, track top-of-funnel content downloads, such as educational white papers or webinars that attract people. Consideration contenders. Okay, they know you. Are they actually thinking about you? Measure time spent on your website and pages per session. Are they digging deep into your solutions? Track engagement with mid-funnel content like case studies or demo requests, which signal serious interest. Conversion champions. This is where the rubber hits the road. How many of those interested folks are becoming actual qualified leads? Focus on the conversion rate from demo to meeting or early pilot program signups. This shows you're turning curiosity into commercial traction. Loyalty legends. Once they're in, are they sticking around and telling their friends? Track customer retention rates, referrals, and the generation of new positive testimonials or case studies. This proves your solution isn't just a flash in the pan. Traction plan, the commercial de-risking duo. In life sciences, two metrics stand above all others when it comes to de-risking your venture for serious capital. These are mandatory proof points that you must track, report, and frame as commercial progress. IP strength, the commercial moat metric. Track the filing status and successful granting of key patents in major commercial jurisdictions, US, EU, Canada. This is a metric of defensible value. Value metric. Patents granted filed in target markets per quarter. So what? Directly quantifies the size and depth of your commercial moat, proving to investors that your innovation cannot be easily replicated and ensuring maximum. Equity value. Regulatory foresight, the timeline validation metric. Track key Health Canada and FDA pre-submission engagements and your adherence to the regulatory timeline. This is a metric of execution and predictability. Value metric percentage of regulatory milestones hit on schedule. For example, successful pre-IND meeting, phase one approval date locked. So what? Directly validates your glow-to-market timeline and proves your team's execution capability, which are critical for an investor making a long-term bet in a capital-intensive sector. Exercise 13-1, the Metric Mastermind Audit. Description. Stop playing the numbers game with vanity statistics and start tracking what matters. This audit guides you to categorize your current metrics by customer journey stage, awareness to loyalty. Identify true North metrics that actually signal growth, and subject them to the so what challenge to ensure every number you track helps you make a business decision. Goal: Move beyond vanity metrics to identify and track indicators of real, quantifiable commercial growth. The worksheet for this exercise is provided in the free Marketing Foundation's workbook as one of five key exercises to start crafting your venture's commercialization platform. Download it now at allgoodmarketing.ca.

Gizmo 9:53

Marketing Nerd Alert. This exercise directly applies principles of key performance indicators, KPIs, and marketing funnel analysis. By shifting your focus from vanity metrics to actionable metrics that track genuine progress throughout the customer journey, you're embracing a data-driven decision-making approach for return on marketing investment, ROMI, which is crucial for early stage companies.

Marketing-qualified vs. sales-qualified leads: what’s the difference?

Kris 10:21

Marketing qualified versus sales-qualified leads. What's the difference? Alright, let's talk about the leads, eh? When you're an early stage life sciences founder, lead scoring might sound like something out of a textbook for a megacorp with a sales team bigger than a Brontosaurus. But hold your horses. It's not about slapping arbitrary points on every website visitor. It's about systematically identifying who's genuinely interested and who's just window shopping for cool science. Think of it this way: Marketing Qualified Leads, MQLs. These are individuals who have shown some interest in your offering through engagement with your marketing efforts. Maybe they downloaded your killer white paper, attended a webinar, or visited a few key pages on your website. They are curious and engaged, but not necessarily ready for a sales pitch. They've raised their hand, but they're still figuring out what they're asking for. Sales qualified leads, SQLs. Now we're talking. These are the gold-plated leads, the ones who have signaled a clear intent to buy or partner and whose needs align directly with your solution. They've not only consumed your content, but have also explicitly asked for a demo, a meeting, or detailed pricing info. For early stage life sciences founders, identifying these folks means validating market interest and pointing you directly towards that elusive product market fit. It's about ensuring you're chasing opportunities that genuinely value what you're building, not just every shiny object. Traction plan. Alright, future unicorns, let's get you scoring smarter, not harder. This isn't about guesswork, it's about making sure your efforts convert into real commercial traction. Define your ideal customer, even if it's a moving target. Before you can score, you need a hypothesis of who you're looking for, who's experiencing that unmet need you're solving, what industries, roles, or organizations would benefit most. Don't create a technology push without apparent market demand. Look for market pull. Your scoring criteria should align with this ideal, even if it shifts. Track engagement, not just visits. A website visit is cool, but a download of your white paper, attendance at your webinar, or a click on a specific solutions page, that's gold. These are signals of deeper interest. Measure impact, not just activity. Grow your business by focusing on results and key performance indicators, KPIs. Qualify, don't just quantify. In the early days, a few deep conversations are worth a thousand casual clicks. Use lead scoring to prioritize who you or your small team should speak with directly. This means looking beyond points and assessing the quality of the engagement. Are they asking insightful questions? Do their problems align with your solution? Are they senior enough to make a decision? Continually asking what else is a brilliant technique for getting to the underlying truth from potential partners or investors. Iterate and learn. Your lead scoring model is a living document, especially when product market fit is still evolving. Test your assumptions. If leads you're scoring high aren't converting, adjust your criteria. Have enough of a buffer so you can make it fun, and embrace the idea that what doesn't kill you makes you stronger, implying an iterative, resilient approach to business. Be agile and ready to pivot based on the data. Exercise 13.2, the Fitfinder Scorecard. Description. Stop wasting time on tire kickers and start quantifying real interest. You will define the top three attributes of your ideal customer and assign point values to specific digital behaviors, like downloading a white paper versus just visiting the home page, to build a lead scoring model that tells you exactly who is ready for a conversation. Goal: Create a preliminary lead scoring model to focus resources on high quality prospects rather than just chasing volume. Exercise worksheets are provided in the accompanying commercialization workbook.

Gizmo 15:17

Marketing Nerd Alert. This exercise integrates the principles of lead qualification and product market fit. By defining ideal customer attributes and assigning value to engagement actions, you create a preliminary lead scoring model that helps focus early stage resources effectively, avoiding the technology pusht trap and moving towards sales pipeline generation.

How to set and hit KPIs when you don’t have historical data

Kris 15:45

How to set and hit KPIs when you don't have historical data. Alright, Ontario Founders, let's be honest. When you're building something groundbreaking, historical data can feel like a mythical creature, rarer than the ogopogo. You're not just trying to hit targets, you're setting them in uncharted territory. How do you set and hit key performance indicators, KPIs, when you're writing the rule book as you go? It's a common Canadian conundrum in early stage life sciences. You've got the science, the passion, but maybe not a decade of sales data to benchmark against. This isn't about pulling numbers out of a toque. It's about being strategic, nimble, and laser-focused on what signals real progress when every step feels like a giant leap into the unknown. The goal is to establish meaningful indicators that help you learn, iterate, and prove traction, even if you're still defining product market fit. Traction plan. When you're sailing without a map, your KPIs become your compass. Don't let the lack of historical data deter you. It's an opportunity to be nimble and data-driven from day one. Things will also take longer than you expect they will. So patience isn't just a virtue, it's a survival skill. Start with hypothesis-driven KPIs. You might not have past data, but you have educated guesses. What do you expect to see? Define your ideal customer, even if it's a moving target, focusing on market pull rather than just pushing your tech. Your initial KPIs should test these hypotheses. Focus on leading indicators. Don't just wait for the significant revenue numbers, lagging indicators. Track leading indicators that show momentum towards those big numbers. For example, instead of just tracking sales, track your website's engagement rate, demo requests, or positive feedback from early pilot users. These early signals tell you if you're on the right track. Break down big goals into micro milestones. If your goal is to secure Series A funding, what are the smaller, measurable steps? Get three follow-up meetings per quarter. Each micro milestone can have its own KPI. Leverage qualitative data from early adopters. In the absence of large data sets, deep conversations with early users are gold. Are they finding value? What problems are they actually solving with your solution? Use these insights to refine your understanding of market pull and adjust your KPIs. The what else technique is perfect for this. Iterate relentlessly and follow the data. Your first set of KPIs won't be perfect, and that's okay. What doesn't kill you makes you stronger. Take a resilient, iterative approach. Be prepared to adjust your KPIs as you learn more, remaining committed to following the data wherever it leads. Exercise 13-3, the First Ascent KPI planner. Description. Navigate the fog of war when you lack historical data by establishing hypothesis-driven targets. In this planner, you will define three strategic objectives for the next six months and identify specific leading indicators, like pilot program satisfaction or investor intro rates, that signal you are on the right path before the revenue numbers arrive. Goal: Establish measurable, actionable performance indicators to track momentum even in the pre-revenue or pre-data stage. Exercise worksheets are provided in the accompanying commercialization workbook.

Gizmo 20:07

Marketing Nerd Alert. This exercise applies principles of goal setting, SMART goals, and leading versus lagging indicators. By focusing on measurable, actionable steps that precede ultimate financial outcomes, you can establish a practical framework for performance measurement and iterative development, even in the absence of extensive historical data, which is critical for securing early stage investment.

Tools that help (and ones that overcomplicate everything)

Kris 20:36

Tools that help, and ones that overcomplicate everything. Alright, let's talk about the digital toolkit, eh? In the wild world of life sciences, there are more marketing and analytics tools out there than mosquitoes in cottage country. Some are helpful, some just buzz around and overcomplicate everything. It's easy to get sucked into the hype of the latest, most complex platform, thinking that more features equal more success. Newsflash. Just like your pitch, clarity always beats density. The goal here isn't to collect every shiny new toy, it's to find the tools that genuinely help you simplify the complicated, track what truly matters, and keep your focus laser sharp. We're looking for efficiency, not just more data to drown in. Avoid tools that promise the moon, but deliver a pile of unreadable spreadsheets, distracting you from your core mission of bringing life changing discoveries to market. You want gear that helps you, not overwhelms you. Remember, if you can't simplify the Complicated, you'll face a greater challenge. The right tools should help you follow the data effectively. Your CRM, Customer Relationship Management. Your relationship, HQ. This is your central hub for tracking interactions with potential investors, partners, and leads. Log every conversation, email, and touch point to understand and nurture relationships through the long sales cycle standard in life sciences. Google Analytics is your buddy. You need to know what's happening on your website. This free tool is powerful enough for most early stage startups to track key awareness and consideration metrics, such as unique visitors, time on site, and conversion events, for example, white paper downloads. Email marketing platforms. Keep it personalized. For nurturing leads and communicating with specific audiences, investors, clinicians, a good email platform is essential. Select a tool that enables audience segmentation, allowing your messages to be tailored and authentic. Tools that overcomplicate. Avoid anything that requires a full-time expert if you don't have one. Avoid platforms with a gazillion features you'll never use. Complexity breeds confusion and wastes precious time that could be spent on actual science or fundraising. Exercise 13-4. The Lean and Mean Toolkit Audit. Description. Rate its actual effectiveness in providing insights, and ruthlessly cut the nice to haves that add complexity without clarity, ensuring your budget fuels growth, not software subscriptions. Goal. Optimize your marketing technology stack to maximize efficiency and insight while minimizing cost and complexity. Exercise worksheets are provided in the accompanying commercialization workbook.

Gizmo 24:19

Marketing Nerd Alert. This audit promotes resource optimization and a lean startup approach to marketing technology. By critically evaluating the necessity and actual utility of tools, you can avoid unnecessary expenses and focus on maximizing output from minimal inputs, ensuring your technology supports KPI tracking and strategic growth.

Reporting tips that impress investors and keep you focused

Kris 24:46

Reporting tips that impress investors and keep you focused. You have the data. You have the metrics, but presenting them to investors is like dropping a new track. It needs to be a hit, not just noise. Your board reports aren't just for showing off your pretty charts. They're your chance to tell a strategic story that keeps investors focused on the big picture and makes them eager to open their wallets. This isn't about burying them in a data dump that's thicker than an Arcteryx coat. It's about translating complex scientific progress and commercial efforts into clear, compelling insights that scream, we're going somewhere big and we know exactly how to get there. You need to impress, inform, and keep that crucial funding flowing. It's about linking design and clinical impact directly to equity value. Traction plan. All right, your board report is your chance to turn numbers into a narrative that impresses investors and keeps everyone laser-focused on the prize. Lead with the so what? The big picture. Don't start with raw data. Begin with the strategic implications and overall progress towards your business goals. Explain your complex insights in lay terms for decision makers. What's the most important takeaway? Hit them with that first. Connect metrics to strategic goals. Every metric should link back to your core objectives, especially your path to commercialization. The clinical impact should be reflected in the equity value. Demonstrate how your marketing metrics contribute to that value. Highlight key performance indicators, KPIs, and progress. Focus on the three to four KPIs that truly matter. Show trends, current performance, and future projections for these critical metrics. Use visuals for clarity, not clutter. Use clean, clear charts and graphs. Avoid visual clutter that confuses investors. White space is your friend for professionalism and readability. Tell a story of traction and potential. Weave data into a compelling narrative showcasing traction, lessons learned, and your future vision. Storytelling is crucial for capturing attention. Don't underestimate the importance of achieving a fair return to support further ambition. Demonstrate reliability. Exercise 13-5, the Investor Impact Report Outline. Description. Transform your board updates from boring data dumps into compelling strategic narratives. You will structure a three-slide executive summary that translates your key metrics into so what insights for investors, linking every data point from diagnostic accuracy to lead conversion directly to your venture's commercial value and future funding needs. Goal: communicate progress and challenges effectively to build investor confidence and demonstrate continued investment readiness. Exercise worksheets are provided in the accompanying commercialization workbook.

Gizmo 28:26

Marketing Nerd Alert. This exercise integrates strategic communication, data visualization, and investor relations. By focusing on a straightforward narrative, emphasizing the so what for investors, and proactively addressing challenges, you build credibility and demonstrate investment readiness, ultimately enhancing your perceived equity value.

 Conclusion

Kris 28:51

Conclusion. Measure what truly matters. Founders, you've got the brains, the grit, and the groundbreaking research that Ontario is known for. But to truly unleash your potential and ensure our province remains a global leader in life sciences, you need to master your marketing math. It's about turning your innovation into a quantifiable impact that the world wants to buy. By stopping the chase for vanity metrics and focusing relentlessly on what truly drives awareness, consideration, conversion, and loyalty, you're not just optimizing your dashboard, you're building a movement. You're ensuring your life-changing discoveries don't just stay in the lab, but transform into products the world wants to buy. So go forth, measure what truly matters, and make those life-changing discoveries a reality.

Gizmo 29:52

So I shouldn't fill my board report with charts just to look busy.

Kris 29:57

That's a rookie move, Giz. We learned that investors don't want a data dump, they want a strategic story. We covered the commercial de-risking duo, IP strength, and regulatory foresight, because those are the only numbers that truly prove you have a commercial moat.

Gizmo 30:15

We also ran the lean and mean toolkit audit. Deleting the shiny tools that just add complexity.

Kris 30:22

That's the rule. We talked about distinguishing between marketing qualified leads who are just browsing and sales qualified leads who are ready to buy. And remember, if you need help passing the so what challenge on your next report, the team at all good marketing is ready to help you make those numbers sing.

Gizmo 30:45

Rerouting. Optimizing for conversion champions only.

Kris 30:49

Smart move. Up next, chapter 14. Brand isn't a logo, it's a legacy.

Gizmo 30:58

The grand finale.

Kris 31:06

Keep glowing, Ontario.

Gizmo 31:07

Until next time. Stay commercial, beasts.

Tangela 31:13

Don't just listen, do the work. Kickstart your glow up with the Free Marketing Foundation's workbook. Five essential step by step exercises to craft your venture's commercial platform. Grab your copy now at allgoodmarketing.ca